BRIEF published on 09/02/2024 at 22:10, 2 months 18 days ago Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device FDA Approval Sleep Apnea Nyxoah U.S. Market Launch Genio® Device
PRESS RELEASE published on 09/02/2024 at 22:05, 2 months 18 days ago Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device Nyxoah rings the Nasdaq Closing Bell as it prepares for the U.S. market launch of its innovative sleep apnea device, Genio. FDA approval expected by end of 2024 FDA Approval Nasdaq Sleep Apnea Nyxoah Genio
BRIEF published on 08/06/2024 at 22:10, 3 months 14 days ago Nyxoah publie ses résultats financiers pour le deuxième et le premier semestre 2024 Augmentation De Capital Hausse Des Revenus Faits Saillants Opérationnels Soumission À La FDA Résultats Du Deuxième Trimestre 2024
BRIEF published on 08/06/2024 at 22:10, 3 months 14 days ago Nyxoah Reports Financial Results for Q2 and H1 2024 Revenue Growth Capital Raise Operational Highlights FDA Submission Q2 2024 Results
PRESS RELEASE published on 08/06/2024 at 22:05, 3 months 14 days ago Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results Nyxoah SA reports financial and operating results for the second quarter and first half of 2024, including FDA submission completion and U.S. approval progress Financial Results Operating Results FDA Submission Nyxoah SA U.S. Approval
BRIEF published on 07/15/2024 at 08:20, 4 months 6 days ago Nyxoah nomme Scott Holstine au poste de directeur commercial Approbation De La FDA Nyxoah Apnée Obstructive Du Sommeil Scott Holstine Industrie Des Dispositifs Médicaux
BRIEF published on 07/15/2024 at 08:20, 4 months 6 days ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer FDA Approval Medical Device Industry Nyxoah Obstructive Sleep Apnea Scott Holstine
PRESS RELEASE published on 07/15/2024 at 08:15, 4 months 6 days ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer Nyxoah appoints Scott Holstine as Chief Commercial Officer, bringing 26 years of medical device industry experience. His role is crucial for Nyxoah's U.S. launch success in treating Obstructive Sleep Apnea Chief Commercial Officer Medical Technology Nyxoah Obstructive Sleep Apnea Scott Holstine
BRIEF published on 07/03/2024 at 12:35, 4 months 17 days ago Nyxoah Signs €37.5 Million Loan Agreement with European Investment Bank Loan Agreement Medical Technology European Investment Bank Nyxoah Obstructive Sleep Apnea
BRIEF published on 07/03/2024 at 12:35, 4 months 17 days ago Nyxoah signe un accord de prêt de 37,5 millions d'euros avec la Banque européenne d'investissement Technologie Médicale Accord De Prêt Banque Européenne D'investissement Nyxoah Apnée Obstructive Du Sommeil
Published on 11/21/2024 at 10:03, 1 hour 31 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 34 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 34 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 59 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 11 hours 9 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 11:01, 33 minutes ago Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 34 minutes ago First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 37 minutes ago ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 4 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 1 hour 29 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 06:58, 4 hours 36 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 36 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 36 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 26 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 14 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
